NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases

Neurodegenerative diseases are chronic debilitating conditions, characterized by progressive loss of neurons that represent a significant health care burden as the global elderly population continues to grow. Over the past decade, high-throughput technologies such as the Affymetrix GeneChip microarrays have provided new perspectives into the pathomechanisms underlying neurodegeneration. Public transcriptomic data repositories, namely Gene Expression Omnibus and curated ArrayExpress, enable researchers to conduct integrative meta-analysis; increasing the power to detect differentially regulated genes in disease and explore patterns of gene dysregulation across biologically related studies. The reliability of retrospective, large-scale integrative analyses depends on an appropriate combination of related datasets, in turn requiring detailed meta-annotations capturing the experimental setup. In most cases, we observe huge variation in compliance to defined standards for submitted metadata in public databases. Much of the information to complete, or refine meta-annotations are distributed in the associated publications. For example, tissue preparation or comorbidity information is frequently described in an article’s supplementary tables. Several value-added databases have employed additional manual efforts to overcome this limitation. However, none of these databases explicate annotations that distinguish human and animal models in neurodegeneration context. Therefore, adopting a more specific disease focus, in combination with dedicated disease ontologies, will better empower the selection of comparable studies with refined annotations to address the research question at hand. In this article, we describe the detailed development of NeuroTransDB, a manually curated database containing metadata annotations for neurodegenerative studies. The database contains more than 20 dimensions of metadata annotations within 31 mouse, 5 rat and 45 human studies, defined in collaboration with domain disease experts. We elucidate the step-by-step guidelines used to critically prioritize studies from public archives and their metadata curation and discuss the key challenges encountered. Curated metadata for Alzheimer’s disease gene expression studies are available for download. Database URL: www.scai.fraunhofer.de/NeuroTransDB.html

[1]  Pierre N Tariot,et al.  Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment , 2006, Neurology.

[2]  D Commenges,et al.  Mortality with dementia: results from a French prospective community-based cohort. , 2001, American journal of epidemiology.

[3]  Alina Solomon,et al.  Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia , 2011, International journal of geriatric psychiatry.

[4]  Eric M. Blalock,et al.  Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease , 2011, Journal of Chemical Neuroanatomy.

[5]  Samira N. Kashefi,et al.  Effects of Antemortem and Postmortem Variables on Human Brain mRNA Quality: A BrainNet Europe Study , 2010, Journal of neuropathology and experimental neurology.

[6]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[7]  Wei-Chung Cheng,et al.  Microarray meta-analysis database (M2DB): a uniformly pre-processed, quality controlled, and manually curated human clinical microarray database , 2010, BMC Bioinformatics.

[8]  Chiara Romualdi,et al.  A-MADMAN: Annotation-based microarray data meta-analysis tool , 2009, BMC Bioinformatics.

[9]  Douglas G Altman,et al.  Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray Datasets , 2008, PLoS medicine.

[10]  Leopold Parts,et al.  Gene expression changes with age in skin, adipose tissue, blood and brain , 2013, Genome Biology.

[11]  J. Chin,et al.  Selecting a mouse model of Alzheimer's disease. , 2010, Methods in molecular biology.

[12]  Adam Bachstetter,et al.  TRAUMATIC BRAIN INJURY IN A MOUSE MODEL OF ALZHEIMER'S DISEASE LEADS TO PERSISTENT GLIAL ACTIVATION, CHRONIC PROINFLAMMATORY PHENOTYPE, AND INCREASED COGNITIVE DEFICITS , 2014, Alzheimer's & Dementia.

[13]  William B Goggins,et al.  Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer’s disease , 2013, Translational Neurodegeneration.

[14]  Ayae Kinoshita,et al.  Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes. , 2013, The Journal of clinical investigation.

[15]  Yoav Gilad,et al.  Sex-specific genetic architecture of human disease , 2008, Nature Reviews Genetics.

[16]  Christoph Laske,et al.  Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease , 2013, PloS one.

[17]  G Halliday,et al.  pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium , 2009, Neuropathology and applied neurobiology.

[18]  A. Verkhratsky,et al.  Amyloid-β and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions , 2013, Cell Death and Disease.

[19]  C. Pike,et al.  Gender, sex steroid hormones, and Alzheimer's disease , 2013, Hormones and Behavior.

[20]  Lars Bertram,et al.  Genetic Risk Factors: Their Function and Comorbidities in Alzheimer's Disease , 2011, International journal of Alzheimer's disease.

[21]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[22]  Yidong Chen,et al.  GEOmetadb: powerful alternative search engine for the Gene Expression Omnibus , 2008, Bioinform..

[23]  Magda Tsolaki,et al.  Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation , 2012, Journal of Translational Medicine.

[24]  Wendy Noble,et al.  Neurodegeneration as an RNA disorder , 2012, Progress in Neurobiology.

[25]  J Schröder,et al.  Age and diagnostic performance of Alzheimer disease CSF biomarkers , 2012, Neurology.

[26]  Anatoly L. Mayburd,et al.  Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease , 2013, BMC Systems Biology.

[27]  Claire O'Donovan,et al.  Biocurators and Biocuration: surveying the 21st century challenges , 2012, Database J. Biol. Databases Curation.

[28]  Sabine C. Mueller,et al.  A blood based 12-miRNA signature of Alzheimer disease patients , 2013, Genome Biology.

[29]  Sergio Contrino,et al.  ArrayExpress: a public database of gene expression data at EBI. , 2003, Comptes rendus biologies.

[30]  Sam Buckberry,et al.  massiR: a method for predicting the sex of samples in gene expression microarray datasets , 2014, Bioinform..

[31]  Chronic Disease Division.  Cancer facts and figures , 2010 .

[32]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[33]  Jerry L. Prince,et al.  A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort , 2012, NeuroImage.

[34]  Weixiong Zhang,et al.  Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks , 2010, BMC Systems Biology.

[35]  Anna Zhukova,et al.  Modeling sample variables with an Experimental Factor Ontology , 2010, Bioinform..

[36]  T. Barrette,et al.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.

[37]  Wendy W Chapman,et al.  Recall and bias of retrieving gene expression microarray datasets through PubMed identifiers , 2010, Journal of biomedical discovery and collaboration.

[38]  Marielle Vennemann,et al.  RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays , 2011, International Journal of Legal Medicine.

[39]  Angela Cacace,et al.  Beyond amyloid: Getting real about nonamyloid targets in Alzheimer's disease , 2013, Alzheimer's & Dementia.

[40]  T. Bayer,et al.  Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease. , 2013, Current topics in behavioral neurosciences.

[41]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[42]  Estefanía Cuenca.  Recommendations for Future Research , 2015 .

[43]  Harald Hampel,et al.  Cognitive and behavioural effects of physical exercise in psychiatric patients , 2012, Progress in Neurobiology.

[44]  Lars Lannfelt,et al.  Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study. , 2013, Journal of Alzheimer's disease : JAD.

[45]  Julia Stoyanovich,et al.  AnnotCompute: annotation-based exploration and meta-analysis of genomics experiments , 2011, Database J. Biol. Databases Curation.

[46]  Stanley J. Watson,et al.  Methodological considerations for gene expression profiling of human brain , 2007, Journal of Neuroscience Methods.

[47]  Shyam Visweswaran,et al.  The application of network label propagation to rank biomarkers in genome-wide Alzheimer’s data , 2014, BMC Genomics.

[48]  Huda Akil,et al.  Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. , 2004, Human molecular genetics.

[49]  Suna Kang,et al.  Injection of β-amyloid into the hippocampus induces metabolic disturbances and involuntary weight loss which may be early indicators of Alzheimer’s disease , 2014, Aging Clinical and Experimental Research.

[50]  Jeffrey Cummings,et al.  Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials. , 2012, Archives of neurology.

[51]  Carole A. Goble,et al.  Towards BioDBcore: a community-defined information specification for biological databases , 2011, Database : the journal of biological databases and curation.

[52]  Sandro Sorbi,et al.  Genetics of familial and sporadic Alzheimer's disease. , 2013, Frontiers in bioscience.

[53]  R. Walker,et al.  RNA integrity in post mortem human variant Creutzfeldt–Jakob disease (vCJD) and control brain tissue , 2011, Neuropathology and applied neurobiology.

[54]  Anna Kalbarczyk,et al.  Sex and gender differences in Alzheimer's disease: recommendations for future research. , 2012, Journal of women's health.

[55]  Jeremiah J. Faith,et al.  Many Microbe Microarrays Database: uniformly normalized Affymetrix compendia with structured experimental metadata , 2007, Nucleic Acids Res..

[56]  Pedro G. Ferreira,et al.  Transcriptome and genome sequencing uncovers functional variation in humans , 2013, Nature.

[57]  Carol A. Tamminga,et al.  Human postmortem tissue: What quality markers matter? , 2006, Brain Research.

[58]  S. Horvath,et al.  Genes and pathways underlying regional and cell type changes in Alzheimer's disease , 2013, Genome Medicine.

[59]  Renee Shaw,et al.  Region‐specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin , 2010, Epilepsia.

[60]  Debomoy K Lahiri,et al.  MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed. , 2011, Biochemical and biophysical research communications.

[61]  Hugues Bersini,et al.  InSilico DB genomic datasets hub: an efficient starting point for analyzing genome-wide studies in GenePattern, Integrative Genomics Viewer, and R/Bioconductor , 2012, Genome Biology.

[62]  Suzanne Craft,et al.  Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[63]  Evelyn P Whitlock,et al.  Recommendations for Future Research , 2004 .

[64]  Jonathan Pevsner,et al.  Progress in the use of microarray technology to study the neurobiology of disease , 2004, Nature Neuroscience.

[65]  Olga Szczodry,et al.  Modelling Alzheimer-like cognitive deficits in rats using biperiden as putative cognition impairer , 2014, Behavioural Brain Research.

[66]  Anders M. Dale,et al.  Rates of Decline in Alzheimer Disease Decrease with Age , 2012, PloS one.

[67]  Peter A. C. 't Hoen,et al.  Microarray retriever: a web-based tool for searching and large scale retrieval of public microarray data , 2008, Nucleic Acids Res..

[68]  Hiroyuki Arai,et al.  MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[69]  Maia Parsadanian,et al.  Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model. , 2014, Journal of neurotrauma.